The sixth author, Camilla Böckelman, should be noted as contributing equally to this work with the last author, Carina I. Holmberg.
There are errors in the Funding section. The correct funding information is as follows: This study was supported by the Academy of Finland (grants 259797 and 297776), Medicinska Understödsförenigen Liv och Hälsa r.f. (C.I.H.), Sigrid Jusélius Foundation, Finnish Cancer Foundation (C.H), Victoria Foundation (https://victoriastiftelsen.fi/start/), K. Albin Johansson Foundation (L.A.), Finska Läkaresällskapet, the Kurt och Doris Palander Foundation, and the Martti I. Turunen Foundation (A.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
The publisher apologizes for these errors.
- 1. Arpalahti L, Laitinen A, Hagström J, Mustonen H, Kokkola A, Böckelman C, et al. (2018) Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis. PLoS ONE 13(2): e0193125. https://doi.org/10.1371/journal.pone.0193125 pmid:29474458
Citation: The PLOS ONE Staff (2018) Correction: Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis. PLoS ONE 13(5): e0197013. https://doi.org/10.1371/journal.pone.0197013
Published: May 2, 2018
Copyright: © 2018 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.